Letermovir improves the outcome of allogenic stem cell transplantation with anti-thymocyte globulin against acute leukemia and myelodysplastic syndromes.

Prevymis (letermovir) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/41925736

Fumiya Ohara; Hiroya Wakabayashi; Hitomi Sawa; Kenta Motegi; Kotaro Miyao; Masashi Sawa; Shuto Negishi; Yuichiro Inagaki

Apr 2, 2026